Harrisburg, NC -- (SBWIRE) -- 10/30/2020 -- Global Preclinical Imaging Market Research Report published by market insight reports explores the current outlook in Global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the Global market, and divides the Market into several parameters.
This Preclinical Imaging Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected growth of the Global market for approaching years from 2019 to 2025. This research report has been aggregated on the basis of static and dynamic aspects of the businesses.
The preclinical imaging market is expected to register a CAGR of nearly 6.00% during the forecast period. This report is segmented by modality and geography.
The major factors leading to the growth of the preclinical imaging market include the technological advancements in molecular imaging, increasing demand for non-invasive small animal imaging techniques, and an increase in preclinical research funding, by both private and public organizations.
Molecular imaging is a rapidly developing multidiscipline, which involves molecular biology, chemistry, computer, engineering, and medicine. It can recognize non - invasive and real-time visualization, measurement of the physiological or pathological process in the living organism at the cellular or molecular level.
Click Here to Get Sample PDF Copy of Latest Research on Preclinical Imaging Market 2019:
https://www.marketinsightsreports.com/reports/10192357320/preclinical-imaging-market-growth-trends-and-forecasts-2020-2025/inquiry?Mode=18
The prominent players in the Global Preclinical Imaging Market:
Aspect Imaging Ltd, Bruker Corporation, Fujifilm Holdings Corporation, Li-Cor Biosciences, Mediso Ltd, and Others.
Key Market Trends: -
Micro-Ultrasound is the Segment by Modality and is Expected to be the Fastest Growing Market
Micro-ultrasound is a miniature version of ultrasound that has a wider range of applications, especially in research related to the small animal models. These smaller versions of imaging techniques boost the efficacy of the techniques. Additionally, they reduce the number of animals required for a particular study. Over the past decade, preclinical imaging has emerged as an important tool to facilitate biomedical discovery. The high-frequency micro-ultrasound steadily evolved in the post-genomic era as a rapid, comparatively inexpensive imaging tool for studying normal development, and models of human disease in small animals. One of the fundamental barriers to this development was the technological hurdle associated with high-frequency array transducers. The applications of preclinical micro-ultrasound are explored for developmental biology, cancer, and cardiovascular disease. With respect to the future, the latest developments in high-frequency ultrasound imaging are also being developed. The combination of multiple imaging modalities in preclinical studies will help the researchers to understand the molecular, cellular, and physiological changes in living animals and to predict the outcome of new treatments in patients. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.
North America is Expected to Dominate the Preclinical Imaging Market
North America is expected to dominate the preclinical imaging market, due to the fact that the region has the developed infrastructure, a large number of preclinical projects, and higher adoption rates of technically advanced devices in the region.
The United States is also found to be dominating the market, owing to the presence of established infrastructure and the presence of major public and private companies.
The preclinical imaging is increasingly used in target identification, compound optimization, and in the drug development process.
The increased research and development funding that is taking place, coupled with the presence of a highly developed research infrastructure, is accelerating the growth of the preclinical imaging market in the United States.
Also, market players are partnering with distributors to increase their product reach. For instance, in September 2017, Aspect Imaging, one of the market player in design and development of compact magnetic resonance systems for preclinical, medical, and industrial applications, announced that Quantum analytics would be its exclusive US Distributor for Aspect Imagings Industrial product portfolio.
Significant Features that are under Offering and Key Highlights of the Reports:
– Detailed overview of Preclinical Imaging Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application etc.
– Historical, current and projected market size in terms of volume and value
– Recent industry trends and developments
– Competitive landscape of Preclinical Imaging Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth
Browse in-depth and report summary TOC on "Preclinical Imaging Market":
https://www.marketinsightsreports.com/reports/10192357320/preclinical-imaging-market-growth-trends-and-forecasts-2020-2025?Mode=18
Finally, the Preclinical Imaging market report offers a complete and detailed study of Global Preclinical Imaging market by using numerous analytical tools and models such as SWOT analysis, investment return analysis, and porter's five forces analysis which are useful for beginners to access the upcoming opportunities. After exploring the market insights through primary and secondary research methodologies, if anything is required except than this, market insight reports will provide customization as per specific demands.
Note: - All the reports that we list have been tracking the impact of COVID-19 the market. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.